Drug Trial Registrations Must Have “Useful Information,” Journal Editors Say
This article was originally published in The Pink Sheet Daily
Executive Summary
International Committee of Medical Journal Editors says some manufacturers are using a “meaningless phrase” in place of a drug’s name for trial registries. Editors adopt WHO minimal registration data set of 20 items; registrations with missing fields or fields with “uninformative terminology” will be considered “inadequate.”
You may also be interested in...
IoM Convenes National Clinical Trials Registry Workshop June 27
International Committee of Medical Journal Editors will outline their clinical trial registry requirements at June 27 IoM workshop as ICMJE's registration deadline approaches. CDER Office of Medical Policy Director Robert Temple will present FDA's perspective.
IoM Convenes National Clinical Trials Registry Workshop June 27
International Committee of Medical Journal Editors will outline their clinical trial registry requirements at June 27 IoM workshop as ICMJE's registration deadline approaches. CDER Office of Medical Policy Director Robert Temple will present FDA's perspective.
Medical Journals To Require Registration Of All Controlled Trials On ClinicalTrials.gov
The International Committee of Medical Journal Editors will require that studies be registered at or before patient enrollment in order to be considered for publication. A Sept. 9 editorial notes that only ClinicalTrials.gov currently fits ICMJE registry criteria.